Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission-Reference-Cited by-同舟云学术

Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission

Published:2016-09-26 Issue:1 Volume:52 Page:163-166
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Saraceni F, ,Bruno B,Lemoli R M,Meloni G,Arcese W,Falda M,Ciceri F,Alessandrino E P,Specchia G,Scimè R,Raimondi R,Bacigalupo A,Bosi A,Onida F,Rambaldi A,Bonifazi F,Olivieri A

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2016233.pdf

Reference15 articles.

1. Messerer D, Engel J, Hasford J, Schaich M, Ehninger G, Sauerland C et al. Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia. Haematologica 2008; 93: 826–833.

2. Vellenga E, van Putten W, Ossenkoppele GJ, Verdonck LF, Theobald M, Cornelissen JJ et al. Autologous peripheral blood stem cell transplantation for acute myeloid leukemia. Blood 2011; 118: 6037–6042.

3. Keating A, DaSilva G, Perez WS, Gupta V, Cutler CS, Ballen KK et al. Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation Research. Haematologica 2013; 98: 185–192.

4. Cornelissen JJ, Versluis J, Passweg JR, van Putten WLJ, Manz MG, Maertens MG et al. Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40–60 years. Leukemia 2015; 29: 1041–1050.

5. Gorin NC, Labopin M, Piemontese S, Arcese W, Santarone S, Huang H et al. T-cell-replete haploidentical transplantation versus autologous stem cell transplantation in adult acute leukemia: a matched pair analysis. Haematologica 2015; 100: 558–564.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML;HemaSphere;2023-11-21

2. Autologous stem cell transplantation in adult patients with intermediate-risk acute myeloid leukemia in first complete remission and no detectable minimal residual disease. A comparative retrospective study with haploidentical transplants of the global committee and the ALWP of the EBMT;Bone Marrow Transplantation;2023-08-28

3. Safety and efficacy of a modified busulfan/cyclophosphamide conditioning regimen incorporating cladribine for autologous hematopoietic stem cell transplantation in acute myeloid leukemia;Frontiers in Pharmacology;2023-02-03

4. Outcome of autologous stem cell transplantation in patients with favorable-risk acute myeloid leukemia in first remission;Cancer Cell International;2022-10-31

5. Trials and Tribulations in the Frontline Treatment of Older Adults with Acute Myeloid Leukemia;Hemato;2021-08-18